INHIBIKASE THERAPEUTICS INC

IKTNASDAQ

🏆 #3428 by market capEarnings Nov 12US Equity

$2.02▼ $0.03 (−1.46%)

🌙 After hours$2.06▲ 1.98%Regular close · extended-hours price shown

🔔

Track IKT

Get earnings, price moves & breaking news on Telegram

Track

24h▼ 1.5%

7d▼ 6.5%

14d▼ 12.6%

30d▼ 12.6%

ytd▼ 1.9%

1y▲ 25.1%

🏦Market Cap

$317M

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

25.0%

Strong

⚖️P/S Ratio

893.9x

Expensive

Otter Score

Weak

Earnings

Q3 · 2026Reported 2026-08-11

Earnings Per Share

Actual

-0.11

Expected

-0.11

miss

−2.30%

YoY +0.00%

Revenue

Actual

—

Expected

—

Consensus estimates

Recent quarters

Q3 2026

-0.11

miss

Q2 2026

-0.10

inline

Q1 2026

-0.09

beat

Q4 2025

-0.13

inline